Back

Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer

2024-02-05 oncology Title + abstract only
View on medRxiv
Show abstract

BackgroundPlatinum chemotherapy is the cornerstone of treatment for high-grade serous ovarian cancer (HGSOC); however, validated biomarkers that can accurately predict platinum response are lacking. Based on their roles in the underlying pathophysiology, circulating microRNAs are potential, noninvasive biomarkers in cancer. In the present study, we aimed to evaluate the circulating miRNA profiles of patients with HGSOC and to assess their potential utility as biomarkers to predict platinum respo...

Predicted journal destinations